Tags

Type your tag names separated by a space and hit enter

[A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].
Schweiz Med Wochenschr. 2000 Mar 11; 130(10):356-61.SM

Abstract

The new recreational drug, gamma-hydroxybutyrate (GHB, "liquid ecstasy"), reached Switzerland in 1998. We describe two cases from the city of Zurich. In both of them the subjects were profoundly unconscious and needed hospitalization after intake of a colourless liquid. Both patients recovered after a few hours, rapidly and without after-effects. Gamma-hydoxybutyrate is abused mainly for its euphorigenic and sedative properties by young people in discos, at raves, or on the drug scene. It is also taken as an alleged anabolic agent among bodybuilders. Criminals use it to narcotise potential victims. We summarise its effects, adverse effects, diagnosis, treatment, toxicology, pharmacology, and medical applications.

Authors+Show Affiliations

Chemisch-toxikologische Abteilung, Universität Zürich-Irchel.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

ger

PubMed ID

10763213

Citation

Iten, P X., et al. "[A New Drug Reaches Switzerland: Coma After Intake of Gamma-hydroxybutyrate (GHB)]." Schweizerische Medizinische Wochenschrift, vol. 130, no. 10, 2000, pp. 356-61.
Iten PX, Oestreich A, Lips R, et al. [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)]. Schweiz Med Wochenschr. 2000;130(10):356-61.
Iten, P. X., Oestreich, A., Lips, R., & Brabetz, M. (2000). [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)]. Schweizerische Medizinische Wochenschrift, 130(10), 356-61.
Iten PX, et al. [A New Drug Reaches Switzerland: Coma After Intake of Gamma-hydroxybutyrate (GHB)]. Schweiz Med Wochenschr. 2000 Mar 11;130(10):356-61. PubMed PMID: 10763213.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)]. AU - Iten,P X, AU - Oestreich,A, AU - Lips,R, AU - Brabetz,M, PY - 2000/4/14/pubmed PY - 2000/5/8/medline PY - 2000/4/14/entrez SP - 356 EP - 61 JF - Schweizerische medizinische Wochenschrift JO - Schweiz Med Wochenschr VL - 130 IS - 10 N2 - The new recreational drug, gamma-hydroxybutyrate (GHB, "liquid ecstasy"), reached Switzerland in 1998. We describe two cases from the city of Zurich. In both of them the subjects were profoundly unconscious and needed hospitalization after intake of a colourless liquid. Both patients recovered after a few hours, rapidly and without after-effects. Gamma-hydoxybutyrate is abused mainly for its euphorigenic and sedative properties by young people in discos, at raves, or on the drug scene. It is also taken as an alleged anabolic agent among bodybuilders. Criminals use it to narcotise potential victims. We summarise its effects, adverse effects, diagnosis, treatment, toxicology, pharmacology, and medical applications. SN - 0036-7672 UR - https://wwww.unboundmedicine.com/medline/citation/10763213/[A_new_drug_reaches_Switzerland:_coma_after_intake_of_gamma_hydroxybutyrate__GHB_]_ L2 - https://medlineplus.gov/clubdrugs.html DB - PRIME DP - Unbound Medicine ER -